Get started
Author

Andri Signorell

Observed names: A Signorell, Signorell, Andri
Observed institutions: Swiss Tropical and Public Health Institute, University of Basel, University of Zurich, University Hospital of Basel, Boston Collaborative Drug Surveillance Program, Helsana Group (Switzerland)
ORCID: 0000-0003-4311-1969
Observed ORCID: 0000-0003-4311-1969
OpenAlex ID: A5082070724
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
2003 · Christoph Hock, Uwe Konietzko, et al. · Neuron · 786
PDF
DescTools: Tools for Descriptive Statistics
2014 · Andri Signorell · 727
PDF
Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42in patients with Alzheimer's disease
2003 · Christoph Hock, Alessia Maddalena, et al. · Amyloid · 112
Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology
2004 · Alessia S. Maddalena, Andreas Papassotiropoulos, et al. · Neurodegenerative Diseases · 74
PDF
Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
2021 · Leander Muheim, Andri Signorell, et al. · Therapeutic Advances in Gastroenterology · 69
PDF
Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data
2013 · Oliver Reich, Andri Signorell, et al. · BMC Health Services Research · 68
PDF
Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims
2017 · Maria M. Wertli, Oliver Reich, et al. · BMC Health Services Research · 58
PDF
Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data
2013 · Carola A. Huber, Sebastian Schneeweiss, et al. · Journal of Clinical Epidemiology · 58
Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care
2023 · Soheila Aghlmandi, Florian S. Halbeisen, et al. · JAMA Internal Medicine · 42
Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data
2019 · Rahel Schneider, Daphne Reinau, et al. · Swiss Medical Weekly · 38
PDF
Perinatal mental disorders in Switzerland: prevalence estimates and use of mental-health services
2017 · Anke Berger, Nicole Bachmann, et al. · Swiss Medical Weekly · 28
PDF
Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland
2016 · Caroline Bähler, Andri Signorell, et al. · PLoS ONE · 28
PDF
How does hospitalization affect continuity of drug therapy: an exploratory study
2016 · Eva Blozik, Andri Signorell, et al. · Therapeutics and Clinical Risk Management · 28
PDF
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life
2015 · Martin K. Schmid, Oliver Reich, et al. · PLoS ONE · 24
PDF
Appropriateness of Diagnostic Coronary Angiography as a Measure of Cardiac Ischemia Testing in Non-Emergency Patients – A Retrospective Cross-Sectional Analysis
2015 · Corinne Chmiel, Oliver Reich, et al. · PLoS ONE · 24
Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims Data
2018 · Daphne Reinau, Matthias Schwenkglenks, et al. · Drug Safety · 22
Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use—A health insurance claims analysis
2020 · Jakob M. Burgstaller, Ulrike Held, et al. · PLoS ONE · 21
Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data
2019 · Rahel Schneider, Daphne Reinau, et al. · Vaccine · 21
The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females—Retrospective Study in 2018–2020
2023 · Yael Rachamin, Levy Jäger, et al. · International Journal of Public Health · 17
Tools for Descriptive Statistics [R package DescTools version 0.99.40]
2021 · Andri Signorell · 13
Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019
2021 · Daphne Reinau, Nadine Schur, et al. · Swiss Medical Weekly · 12
PDF
Intensity of treatment in Swiss cancer patients at the end-of-life
2018 · Caroline Bähler, Andri Signorell, et al. · Cancer Management and Research · 12
PDF
Health Care Utilization and Expenditures in Persons Receiving Social Assistance in 2012 Evidence From Switzerland
2014 · Oliver Reich, Felix Wolffers, et al. · Global Journal of Health Science · 11
PDF
Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012–2021: Are we on track?
2023 · Simeon J. Zürcher, Andri Signorell, et al. · Vaccine · 9
Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data
2020 · Caroline Bähler, Roland Rapold, et al. · International Journal of Public Health · 9
Works count: 70
Citation count: 2,351
H-index: 18
I10-index: 23
Year
Topic
Type